Literature DB >> 9027585

Effect of activating and inactivating mutations of Gs- and Gi2-alpha protein subunits on growth and differentiation of 3T3-L1 preadipocytes.

J O Gordeladze1, K E Høvik, J J Merendino, S Hermouet, S Gutkind, D Accili.   

Abstract

Previous investigations have demonstrated that both Gs- and the Gi-family of GTP-binding proteins are implicated in differentiation of the 3T3-L1 preadipocyte. In order to further analyze the role of Gs alpha vs. Gi2 alpha, which are both involved in adenylate cyclase modulation, we transfected undifferentiated 3T3-L1 cells with two sets of G-protein cDNA: the pZEM vector with either wild type, the activating (i.e., GTP-ase inhibiting) R201C-Gs alpha or the inactivating G226A(H21a)-Gs alpha point mutations, or the pZIPNeoSV(X) retroviral vector constructs containing the Gi2 alpha wild type or the missense mutations R179E-Gi2 alpha, Q205L-Gi2 alpha, and G204A(H21a)-Gi2 alpha. The activating [R201C]Gs alpha-mutant did not significantly affect the differentiation process, i.e., increase in the steady-state levels of G-protein subunits, gross appearance, or insulin-elicited deoxy-glucose uptake into 3T3-L1 adipocytes, despite a marked initial increase in hormone-elicited adenylate cyclase activity. The [H21a]Gs alpha-mutant, on the other hand, enhanced the degree of differentiation slightly, as evidenced by an augmented production of lipid vesicles and insulin-stimulated deoxy-glucose uptake. However, an expected increase in mRNA for hormone-sensitive lipase was not seen. Secondly, it appeared that both activating [R179E]Gi2 alpha or [Q205L]Gi2 alpha mutants reduced cell doubling time in non-confluent 3T3-L1 cell cultures, while [H21a]Gi2 alpha slowed proliferation rate. Furthermore, it seemed that cell proliferation, as evidenced by thymidine incorporation, ceased at a much earlier stage prior to cell confluency when cultures were transfected with the [R179E]Gi2 alpha or [Q205L]Gi2 alpha mutants. Upon differentiation with insulin, dexamethasone, and iBuMeXan, the following cell characteristics emerged: the [R179E]Gi2 alpha and [Q205L]Gi2 alpha mutants consistently enhanced adenylate cyclase activation and cAMP accumulation stimulated by isoproterenol and corticotropin over controls. Deoxy-glucose uptake was also super-activated by the [R179E]Gi2 alpha and [Q205L]Gi2 alpha mutants. Finally, steady-state levels of hormone sensitive lipase mRNA were dramatically increased by [R179E]Gi2 alpha and [Q205L]Gi2 alpha over differentiated controls. The inactivating [H21a]Gi2 alpha-mutant obliterated all signs of preadipocyte differentiation. It is concluded that Gi2 plays a positive and much more important role than Gs in 3T3-L1 preadipocyte differentiation. Cyclic AMP appears to play no role in this process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9027585     DOI: 10.1002/(sici)1097-4644(199702)64:2<242::aid-jcb8>3.0.co;2-x

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  The calcium-sensing receptor promotes adipocyte differentiation and adipogenesis through PPARγ pathway.

Authors:  Yong-Han He; Ying He; Xi-Lu Liao; Yu-Cun Niu; Guan Wang; Chen Zhao; Liang Wang; Ming-Jie Tian; Ying Li; Chang-Hao Sun
Journal:  Mol Cell Biochem       Date:  2011-10-25       Impact factor: 3.396

2.  The inhibitory guanine nucleotide-binding protein Gi2alpha induces and potentiates adipocyte differentiation.

Authors:  K E Høvik; P Wu; J O Gordeladze
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

3.  Biological effects of thyrotropin receptor activation on human orbital preadipocytes.

Authors:  Lei Zhang; Glynn Baker; Dominika Janus; Carol A Paddon; Dagmar Fuhrer; Marian Ludgate
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

4.  Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.

Authors:  V J Watts; B L Wiens; M G Cumbay; M N Vu; R L Neve; K A Neve
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.